Modern stem cell technology is rapidly evolving and holds promise to revolutionize medicine by allowing regeneration of any type of cell within the human body

Management Team and Directors

James R. Musick, Ph.D., President, Chief Executive Officer, and Chairman of the Board of Directors

Dr. Musick founded the Company in its present form and has served in various management capacities since joining the Company in 1988. He earned a Ph.D. degree in biological sciences with a specialty in neuroscience from Northwestern University and completed post-doctoral work at the University of Utah.  His academic career included the position of Assistant Professor of Physiology at the University of Utah, School of Medicine.

He joined Vitro Diagnostics in 1988 and directed all operations involved in the establishment of a diagnostic product line that included about 30 different purified antigen products.  His direct responsibilities included research & development, manufacturing, intellectual property development and maintenance, marketing and sales.  He was also responsible for the development & initial commercialization of the fertility drug VITROPIN™ as well as the cell immortalization program of the Company.  He is an inventor or co-inventor of all issued and pending patents owned by the Company.

In 2000, he orchestrated the successful spin-off of the diagnostic operating division allowing the Company to focus on development of the Core technology of cell immortalization, stem cell line generation while establishing and commercializing initial the stem cell products for use in research and clinical development.

Pete Shuster, Director

Pete Shuster, the CEO of Neuromics, Inc. and was appointed to Vitro Biopharma’s Board of Directors in 2013.  Mr. Shuster is a seasoned and experienced sales executive.  He is the current owner of Neuromics, Inc., a privately held and profitable business focused on sales of numerous (>2500) specialty life science products including stem cell products manufactured by Vitro Biopharma.  Neuromics, Inc. sales have grown over 5.5-fold since inception in 2003.  Shuster has extensive prior experience in managing sales of computer software and related products for companies including Caterpillar, Baxter Healthcare and Harley-Davidson.

He received a Bachelor’s Degree in Biology from Lawrence University in Wisconsin during 1981 and performed graduate studies in biochemistry at the University of Minnesota.  He was in Sales and Sales Management with Teltech from 1985 to 1994 where he was a top producer.  He was a sales representative at Connect, Inc from 1994 to 1995 where he sold systems integration solutions. He was a Major Account manager at SDRC from 1995 to 1999 and Senior Account Manager at EAI for sales of Product Visualization Software.  At both of these firms, he achieved significant sales success including completion of several large transactions. In 1998, he was recognized as the #1 sales person worldwide for total sales of Metaphase Product Data Management solutions with multi-million dollar sales to Harley Davidson, Baxter Healthcare and Sauer Sundstrand.  From 1996 to 2002, he was the founder and owner of Kingdom2.com, an online reseller of re-manufactured satellite systems. From 2000 to 2002 he was Large Account Sales Director of PTC, a company that sold product data management and CAD software, where he lead teams that sold  to heavy equipment manufacturers, including Caterpillar, John Deere and Case. The team achieved sales > $15,000,000 in FY2001.

In 2003, he founded Neuromics, Inc, his present business that is a web-based marketer of reagents to accelerate discovery in Neuroscience, Diabetes/Obesity and Cancer offering products including antibodies, proteins, transfection reagents, stem cell and primary cell lines, cell culture media and apoptosis measurement kits.  He maintains a strong presence in various social media and is responsible for several blogs related to life science products.  He has considerable expertise and experience in strategic selling.

Jeff Liter, Director

Mr. Liter is a versatile business executive who has consistently delivered profitable revenue growth across multiple businesses, industries and geographic regions. He presently serves as the Chief Operating Officer of Progenitor Cell Therapy (PCT), a division of NeoStem a stem cell firm traded on the New York Stock Exchange.  His impressive accomplishments include leading 10 M & A transactions from $4M to $2.6B in their entirety.  It is anticipated that Mr. Liter will accelerate the rapid growth that Vitro Biopharma is now experiencing, especially in enhanced strategic focus, finance, M&A and other growth initiatives as well.

Prior to his position at PCT, Jeff served as managing director of On Point Consulting, a post-acquisition consulting service specialized in the life sciences industry.    From January 2010 to September 2011, he was Director of Strategy, Business Development and Licensing for Beckman Coulter where he was responsible for business development of the immunoassay and molecular diagnostics group. From December 2008 to January 2010 he was managing director of On Point Consulting.  From October 2006 to November 2008, he was Vice President of Corporate Business Development for ADC Telecommunications, a global leader in telecommunications.  He led M&A, minority investments, strategic partnerships, divestitures and business unit strategy development while at ADC.  From 1999 to 2006 he held other positions with ADC Telecommunications including Director of Corporate Development.

He received a BS degree in Business and Industrial Technology from Illinois State University in 1978 and his MBA degree in Finance from the University of Minnesota-Carlson School of Management in 1986.